phlorhizin has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamine, T; Kawanami, D; Matoba, K; Nagai, Y; Sango, K; Takeda, Y; Utsunomiya, K; Yokota, T | 1 |
| Ridgway, TJ; Tucker, GA | 1 |
2 review(s) available for phlorhizin and Cardiovascular Diseases
| Article | Year |
|---|---|
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Phlorhizin; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Prospects for the production and use of new improved dietary oestrogens for cardioprotection.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Diet; Estrogens, Non-Steroidal; Food, Fortified; Humans; Isoflavones; Phlorhizin; Phytoestrogens; Plant Preparations; Plants, Edible; Receptors, Estrogen | 1997 |